Orchid Pharma Limited — Others, 11-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Orchid Pharma has announced a board meeting regarding compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations for the quarter ending March 31, 2025. The compliance certificate from Abhipra Capital Limited, the company's Registrar and Share Transfer Agent, confirms adherence to necessary requirements. This update ensures transparency and governance, reflecting the company’s commitment to maintaining compliance standards. From an investor standpoint, this adherence could foster a positive outlook, enhancing investor confidence in the company’s governance practices.